跳至主要内容
临床试验/NCT04709744
NCT04709744已完成不适用

Impact of Vitamin D Level and Supplement on SLE Patients During COVID-19 Pandemic

Mansoura University1 个研究点 分布在 1 个国家目标入组 38 人开始时间: 2020年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
38
试验地点
1
主要终点
Level of serum vitamin D in SLE infected with COVID-19

研究概览

简要总结

Aim of the work Impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection, duration of COVID-19 disease course, fatigue development as a complication for both SLE and COVID-19 and assess impact of prior chloroquine on COVID-19 disease outcomes Patients and methods 38 SLE patients previously diagnosed and on different lines of lupus management. Participants were presented to chest outpatient clinic and emergency hospital, Mansoura University with manifestation suggesting COVID-19 infection. Serum vit D was measured in serum by ELISA.

详细描述

Primary objective: assess the impact of serum vit D level in SLE patients with COVID-19 disease on severity of infection and pandemic treatment outcome.

Secondary objectives:

  • Effect of serum vit D level in SLE patients on duration of COVID-19 disease course and fatigue development as a complication for both SLE and COVID-19
  • Impact of prior chloroquine on COVID-19 disease outcomes
  • Correlation of serum vit D level with different laboratory investigations at time of COVID-19 outbreak

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • - SLE patients previously diagnosed
  • Patients are not suffering from malignancies.
  • Patients have no organ failure nor uncontrolled medical illness.
  • Recent COVID-19 infection

排除标准

  • - Pregnant, lactating females
  • Concurrent malignancies
  • Patients with other autoimmune disease

研究组 & 干预措施

SLE patients

SLE patients were presented to chest outpatient clinic and emergency hospital, Mansoura University with manifestation suggesting COVID-19 infection. Vit D was measured in serum by ELISA. Vit D was added to anti COVID-19.

干预措施: Vitamin D (Drug)

SLE patients

SLE patients were presented to chest outpatient clinic and emergency hospital, Mansoura University with manifestation suggesting COVID-19 infection. Vit D was measured in serum by ELISA. Vit D was added to anti COVID-19.

干预措施: ELISA (Diagnostic Test)

结局指标

主要结局

Level of serum vitamin D in SLE infected with COVID-19

时间窗: 6 months

Measurement of serum vit D level (ng/ml)

次要结局

  • Vitamin D level with COVID-19 severity(6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yasmin Adel Abdelsalam Hussein

Lecturer of Rheumatology and Rehabilitation

Mansoura University

研究点 (1)

Loading locations...

相似试验